Home
Overview/Our mission
News and Events
Stock Quote
About us
At a glance
Our values
Management team
Board of Directors
Scientific Advisors
Cell Therapy Scientific Advisory Board
Glioblastoma Scientific Advisory Board
Science
NK Cell Derived Allogeneic Therapies
CHM 0201 (CORE-NK Platform)
CHM 0301 (Next Generation CORE-NK Platform)
CHM 1301 (CLTX CAR-NK)
CHM 2301 (CDH17 CAR-NK)
CHM 3301 (Undisclosed CAR-NK)
T Cell Derived Autologous Therapies
CHM 1101 (CLTX CAR T)
CHM 2101 (CDH17 CAR T)
Collaborations
About Cell Therapy
Pipeline
Overview
Clinical Trials
CHM 1101 (CLTX CAR T)
CHM 0201 (CORE-NK Platform)
Abstracts and Publications
News and Events
Press releases
Events and presentations
Media Coverage
Media Resources
Investors
Corporate Profile
Investor News and Events
Annual Report
Press releases
Events and presentations
Analyst Coverage
Shareholder Newsletters
Stock information
Stock quote and chart
Historical price lookup
Corporate Governance
Corporate Charters
Corporate Policies
Resources
Investor Q and A
Email alerts
Investor Contacts
Careers
Menu
Home
Overview/Our mission
News and Events
Stock Quote
About us
At a glance
Our values
Management team
Board of Directors
Scientific Advisors
Cell Therapy Scientific Advisory Board
Glioblastoma Scientific Advisory Board
Science
NK Cell Derived Allogeneic Therapies
CHM 0201 (CORE-NK Platform)
CHM 0301 (Next Generation CORE-NK Platform)
CHM 1301 (CLTX CAR-NK)
CHM 2301 (CDH17 CAR-NK)
CHM 3301 (Undisclosed CAR-NK)
T Cell Derived Autologous Therapies
CHM 1101 (CLTX CAR T)
CHM 2101 (CDH17 CAR T)
Collaborations
About Cell Therapy
Pipeline
Overview
Clinical Trials
CHM 1101 (CLTX CAR T)
CHM 0201 (CORE-NK Platform)
Abstracts and Publications
News and Events
Press releases
Events and presentations
Media Coverage
Media Resources
Investors
Corporate Profile
Investor News and Events
Annual Report
Press releases
Events and presentations
Analyst Coverage
Shareholder Newsletters
Stock information
Stock quote and chart
Historical price lookup
Corporate Governance
Corporate Charters
Corporate Policies
Resources
Investor Q and A
Email alerts
Investor Contacts
Careers
Linkedin-in
Youtube
Twitter
Envelope
Press Releases
March 2022
CORE NK Platform Phase I Clinical Data Presentation
LEARN MORE
Share:
Share on facebook
Share on twitter
Share on linkedin